In a statement, the DILG said that 10,739 PDLs finished their basic education through the Department of Education’s ...

Klotho is advancing its ALS gene therapy candidate KLTO‑202 to the manufacturing phase, and is planning the first human ...

BrainStorm Cell Therapeutics issued a statement Tuesday supporting a Citizens’ Petition submitted to the FDA requesting the ...

The John Carroll Area Ambulance Service has earned a three-year advanced life support license renewal from the Pennsylvania Department of Health Bureau of Emergency Medical Services.

A new drug originally developed to treat a different brain disease is now showing signs that it could help people with ...

During Neuralink’s summer update on the trial, they showed the moment one participant was able to move a cursor with his ...

Look inside a brain cell with Huntington's disease or ALS and you are likely to find RNA clumped together. These solid-like clusters, thought to be irreversible, can act as sponges that soak up ...

There were support groups and he would eventually join an ALS clinic, but no one was documenting the day-to-day of the ...

This year the Syracuse Salt Cats will be holding the annual Community ALS Awareness Night. The event will be happening at Onondaga Community College on Tuesday, July 8. The goal ...

Unlike other interfaces—which sound stiff and robotic, like early smart assistants—this one imitates the sound and cadence of ...

New and Unprecedented Survival, Respiratory, and Biomarker Data Prove that NurOwn Helps People with ALS Live Longer and Live ...

The FDA granted orphan drug designation to Sineugene Therapeutics' SNUG01, a first-in-class experimental gene therapy for ...